Cooley advised Longboard Pharmaceuticals on the offering, and Latham & Watkins advised the underwriters involved.Longboard Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
